GE Healthcare has announced the latest version of its Vivid E9 cardiovascular ultrasound system has received FDA 510(k) clearance, according to a news release.
Features of the Vivid E9 Breakthrough 2012 include a 4D transducer for transesophageal echocardiography, a configurable transesophageal echocardiography transducer, a tilt and rotate function and a live "2-Click Crop" tool, according to the relese.
"The new 4D transesophageal probe developed by GE Healthcare is an advanced diagnostic tool," said Dr. Luigi P. Badano of the University of Padua, Padua, Italy, in the release. "It combines ease of use and flexibility to acquire 4D data sets, user-friendly navigation tools that allow users to quickly visualize the cardiac structure of interest, and effective quantification software to quantitate left ventricular pump function, myocardial deformation and mitral valve morphology."
Related Articles on FDA Clearances:
ActiViews Receives FDA 510(k) Clearance of CT-Guide Needle Guidance System for Liver Interventions
Abbott Receives FDA Clearance for Use of Femtosecond Laser for Arcuate Incisions
CurveBeam Receives FDA 510(k) Approval for the pedCAT 3D Foot and Ankle Scanner